CRISPR Therapeutics AG·4

Oct 18, 8:00 PM ET

Ho Tony W 4

4 · CRISPR Therapeutics AG · Filed Oct 18, 2021

Insider Transaction Report

Form 4
Period: 2021-10-15
Ho Tony W
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-10-15+13,80013,800 total
    Exercise: $97.00Exp: 2031-10-15Common Shares (13,800 underlying)
Footnotes (1)
  • [F1]This option was granted on October 15, 2021 with respect to 13,800 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 15, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION